Brain lactate and N-acetylaspartate in pediatric AIDS encephalopathy.
Steven G. Pavlakis, Dongfeng Lu, Yitzchak Frank, Andrew Wiznia, David Eidelberg, Tracey A. Barnett, Roger A. Hyman
Abstract
Steven G. Pavlakis, Dongfeng Lu, Yitzchak Frank, Andrew Wiznia, David Eidelberg, Tracey A. Barnett, Roger A. Hyman
Abstract
Two children with acquired immunodeficiency syndrome (AIDS) and progressive encephalopathy underwent MR spectroscopy before and after antiretroviral therapy. Initial MR spectroscopy of the basal ganglia region showed decreased N-acetylaspartate (NAA)/creatine (Cr) and a lactate peak. After therapy, there was improvement in NAA/Cr and an absence of the abnormal lactate peak. We suggest that decreased NAA/Cr in AIDS is reversible, that brain lactate might correlate with inflammation, and that MR spectroscopy can be useful in treatment trials.
OpenAlex reports 39 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Two children with acquired immunodeficiency syndrome (AIDS) and progressive encephalopathy underwent MR spectroscopy before and after antiretroviral therapy. Initial MR spectroscopy of the basal ganglia region showed decreased N-acetylaspartate (NAA)/creatine (Cr) and a lactate peak. After therapy, there was improvement in NAA/Cr and an absence of the abnormal lactate peak. We suggest that decreased NAA/Cr in AIDS is reversible, that brain lactate might correlate with inflammation, and that MR spectroscopy can be useful in treatment trials.
Key concepts: Medicine, In vivo magnetic resonance spectroscopy, Encephalopathy, Creatine, Basal ganglia, Central nervous system disease, Internal medicine, Gastroenterology